Open Access move for new look Annals of Medicine journal - Taylor & Francis Newsroom

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Taylor & Francis Group news

Open Access move for new look Annals of Medicine journal

 

26th October 2020

Annals of Medicine

Taylor & Francis’ ever-growing portfolio of fully Open Access journals has been enhanced today, with the addition of Annals of Medicine.

To further encourage greater collaboration and reproducibility, now across more than 30 crucial therapy areas, this long-standing international, general medicine journal is being transformed to a full Open Access publication.
The conversion will see an open data policy, providing the publication of all its high-quality, peer-reviewed research – including null and negative results – under a ‘CC BY’ Creative Commons licensing as standard.

Annals of Medicine publishes original, peer-reviewed research and reviews across all areas of medicine, with content encompassing both translational medicine and clinical practice.
The journal will now be led by a new, larger editorial team with knowledge spanning more than 30 new sections, with therapy areas including Oncology, Cardiology and Infectious Diseases. Each therapy area is overseen by an expert Section Editor, ensuring a constructive and rigorous peer-review process.

In welcoming the move to Open Access, Professor Timo Partonen of the University of Helsinki, who has led the publication as Editor-in-Chief since 2009 and will now become Section Editor for Psychiatry, said: “Annals of Medicine has a rich history in delivering the world’s best clinical science, from bench to bedside. As an Open Access journal our content can, from here onwards, be accessible for free by anyone.”

By publishing all scientifically valid research under ‘CC BY’ Creative Commons license, Annals of Medicine articles will have maximum capability for article sharing.

“This license will enable further research in crucial health topics that matter to each one of us,” states Todd Hummel, Taylor & Francis Global Publishing Director Medicine.

“And, making the highest quality of research freely and permanently available so that anyone, anywhere, can read and build upon this work is amongst our highest priorities at Taylor & Francis.

“Therefore, we are delighted to add Annals of Medicine to its Open Access portfolio – it’s a transition which will be revolutionary for authors looking to publish highly accessible medical research; and for those who already work with this high-profile journal.”

Taylor & Francis is inviting authors to submit high-quality papers, with manuscript types including Research Articles, Study Characteristics, Clinical Study, Systematic Review, Review Article, Mini Review, Case Series, Commentary, and Letters to the Editor.

For more information on how to publish in Annals of Medicine, please visit the journal’s homepage.

Taylor & Francis is also delighted to announce that FinELib, the Finnish library consortium, will also include Annals of Medicine as part of their read & publish agreement, to ensure publication is frictionless for researchers in Finland – paying homage to the journal’s history and popularity within the Finnish medical community.

Arja Tuuliniemi, Head of Licensing for FinELib, says: “As a country, Finland has a goal to reach 100% Open Access. This partnership with Taylor & Francis will enable more researchers from Finland to ‘choose open’.”

To learn more about the journal, please visit Annals of Medicine.